Systematic review with meta-analysis: inflammatory bowel disease in the elderlyGISBERT, J. P; CHAPARRO, M.Alimentary pharmacology & therapeutics. 2014, Vol 39, Num 5, pp 459-477, issn 0269-2813, 19 p.Article

Review article: the effectiveness of standard triple therapy for Helicobacter pylori has not changed over the last decade, but it is not good enoughGISBERT, J. P; CALVET, X.Alimentary pharmacology & therapeutics. 2011, Vol 34, Num 11-12, pp 1255-1268, issn 0269-2813, 14 p.Article

Review article: Helicobacterpylori-negative duodenal ulcer diseaseGISBERT, J. P; CALVET, X.Alimentary pharmacology & therapeutics. 2009, Vol 30, Num 8, pp 791-815, issn 0269-2813, 25 p.Article

Review article: common misconceptions in the management of Helicobacter pylori-associated gastric MALT-lymphomaGISBERT, J. P; CALVET, X.Alimentary pharmacology & therapeutics. 2011, Vol 34, Num 9, pp 1047-1062, issn 0269-2813, 16 p.Article

Review article: rifabutin in the treatment of refractory Helicobacter pylori infectionGISBERT, J. P; CALVET, X.Alimentary pharmacology & therapeutics. 2012, Vol 35, Num 2, pp 209-221, issn 0269-2813, 13 p.Article

Review article: non-bismuth quadruple (concomitant) therapy for eradication of Helicobater pyloriGISBERT, J. P; CALVET, X.Alimentary pharmacology & therapeutics. 2011, Vol 34, Num 6, pp 604-617, issn 0269-2813, 14 p.Article

Systematic review and meta-analysis : levofloxacin-based rescue regimens after Helicobacter pylori treatment failureGISBERT, J. P; DE LA MORENA, F.Alimentary pharmacology & therapeutics. 2006, Vol 23, Num 1, pp 35-44, issn 0269-2813, 10 p.Article

Systematic review and meta-analysis : is 1-week proton pump inhibitor-based triple therapy sufficient to heal peptic ulcer?GISBERT, J. P; PAJARES, J. M.Alimentary pharmacology & therapeutics. 2005, Vol 21, Num 7, pp 795-804, issn 0269-2813, 10 p.Article

Systematic review : infliximab therapy in ulcerative colitisGISBERT, J. P; GONZALEZ-LAMA, Y; MATE, J et al.Alimentary pharmacology & therapeutics. 2007, Vol 25, Num 1, pp 19-37, issn 0269-2813, 19 p.Article

Helicobacter pylori infection and gastric outlet obstruction: prevalence of the infection and role of antimicrobial treatmentGISBERT, J. P; PAJARES, J. M.Alimentary pharmacology & therapeutics. 2002, Vol 16, Num 7, pp 1203-1208, issn 0269-2813Article

Systematic review with meta-analysis: the declining risk of colorectal cancer in ulcerative colitisCASTANO-MILLA, C; CHAPARRO, M; GISBERT, J. P et al.Alimentary pharmacology & therapeutics. 2014, Vol 39, Num 7, pp 645-659, issn 0269-2813, 15 p.Article

Review article: prevention and management of hepatitis B and C infection in patients with inflammatory bowel diseaseGISBERT, J. P; CHAPARRO, M; ESTEVE, M et al.Alimentary pharmacology & therapeutics. 2011, Vol 33, Num 6, pp 619-633, issn 0269-2813, 15 p.Article

Helicobacter pylori 'test-and-treat' strategy for dyspeptic patientsGISBERT, J. P; PAJARES, J. M.Scandinavian journal of gastroenterology. 1999, Vol 34, Num 7, pp 644-652, issn 0036-5521Article

Helicobacter pylori and gastroesophageal reflux disease : Friends or foes?GISBERT, J. P; PAJARES, J. M; LOSA, C et al.Hepato-gastroenterology. 1999, Vol 46, Num 26, pp 1023-1029, issn 0172-6390Article

Letter: mucosal healing in ulcerative colitis - higher relevance than in Crohn's disease?BARREIRO-DE ACOSTA, M; GISBERT, J. P.Alimentary pharmacology & therapeutics. 2013, Vol 38, Num 2, pp 207-210, issn 0269-2813, 4 p.Article

Angiogenesis in inflammatory bowel diseasePOUSA, I. D; MATE, J; GISBERT, J. P et al.European journal of clinical investigation. 2008, Vol 38, Num 2, pp 73-81, issn 0014-2972, 9 p.Article

¹³C-urea breath test in the diagnosis of Helicobacter pylori infection: a critical reviewGISBERT, J. P; PAJARES, J. M.Alimentary pharmacology & therapeutics. 2004, Vol 20, Num 10, pp 1001-1017, issn 0269-2813, 17 p.Article

Helicobacter pylori and bleeding peptic ulcer: What is the prevalence of the infection in patients with this complication?GISBERT, J. P; PAJARES, J. M.Scandinavian journal of gastroenterology. 2003, Vol 38, Num 1, pp 2-9, issn 0036-5521, 8 p.Article

Infliximab salvage therapy after failure of ciclosporin in corticosteroid-refractory ulcerative colitis: a multicentre studyCHAPARRO, M; BURGUENO, P; GOMEZ SENENT, S et al.Alimentary pharmacology & therapeutics. 2012, Vol 35, Num 2, pp 275-283, issn 0269-2813, 9 p.Article

Long-Term Follow-Up of 1,000 Patients Cured of Helicobacter pylori Infection Following an Episode of Peptic Ulcer BleedingGISBERT, J. P; CALVET, X; GARCIA-GRAVALOS, R et al.The American journal of gastroenterology. 2012, Vol 107, Num 8, pp 1197-1204, issn 0002-9270, 8 p.Article

Meta-analysis: esomeprazole or rabeprazole vs. first-generation pump inhibitors in the treatment of Helicobacter pylori infectionMCNICHOLL, A. G; LINARES, P. M; NYSSEN, O. P et al.Alimentary pharmacology & therapeutics. 2012, Vol 36, Num 5, pp 414-425, issn 0269-2813, 12 p.Article

Systematic review: antibodies and anti-TNF-α levels in inflammatory bowel diseaseCHAPARRO, M; GUERRA, I; MUNOZ-LINARES, P et al.Alimentary pharmacology & therapeutics. 2012, Vol 35, Num 9, pp 971-986, issn 0269-2813, 16 p.Article

Systematic review : the adverse effects of sodium phosphate enemaMENDOZA, J; LEGIDO, J; RUBIO, S et al.Alimentary pharmacology & therapeutics. 2007, Vol 26, Num 1, pp 9-20, issn 0269-2813, 12 p.Article

Recurrence of Helicobacter pylori infection after several eradication therapies : long-term follow-up of 1000 patientsGISBERT, J. P; LUNA, M; GOMEZ, B et al.Alimentary pharmacology & therapeutics. 2006, Vol 23, Num 6, pp 713-719, issn 0269-2813, 7 p.Article

Seven versus ten days of rabeprazole triple therapy for Helicobacter pylori eradication : A multicenter randomized trialCALVET, X; DUCONS, J; BUJANDA, L et al.The American journal of gastroenterology. 2005, Vol 100, Num 8, pp 1696-1701, issn 0002-9270, 6 p.Article